Our renowned biennial series of multidisciplinary European Cancer Congresses are recognised as the premier cancer meetings in Europe. At Stockholm in 2011, 15 931 participants from all disciplines experienced the strongest and most forward-focused scientific programme to date.
The 17th ECCO – 38th ESMO – 32nd ESTRO European Cancer Congress, Amsterdam, 27 September – 1 October 2013, will once again combine the united efforts of all partner organisations to continue positioning multidisciplinarity as the way forward to best improve the prevention, diagnosis, treatment and care of cancer patients. The recognised multidisciplinary setting of the Congress will provide ideal surroundings for participants to leverage knowledge, promote education and build awareness about oncology - placing the patient at the heart of all our efforts and discussions.
These are exciting times for the oncology community. Multidisciplinarity represents optimum professional efficiency in practice. However, as the management of cancer research, treatment and care becomes more complex, it is crucial that all key professional groups are able to contribute effectively to ensuring that professional decisions are evidence-based, patient-centred and reached by consensus.
In 2011, we had the largest number of abstracts ever submitted, and the highest amount of new data presented. And 2012 promises to be an even stronger, pioneering programme for showcasing the latest developments in practice-changing studies of new and significant scientific importance. This preliminary announcement provides you with just a taste of what is to come.
The Congress will also strive to further the role of multidisciplinary oncology by encouraging participation and interaction between all oncology professions, irrespective of their focus. We therefore strongly encourage involvement across disciplines and specialist fields and invite you to join our efforts to advance cancer treatment and care by ensuring your discipline or specialist field is well-represented. There is no better way to underpin the importance of your specialty and ensure it makes a tangible contribution in establishing standards for the field of oncology now and into the future.
We look forward to receiving your registration and hearing about your latest data, but most importantly, we look forward to the part you will play in ensuring that existing and future patients benefit from access to innovation, quality treatment and care at the European Cancer Congress in Amsterdam.
Cornelis van de Velde, Congress Chair, ECCO President
PRINT THIS PAGE
Page last modified:
Martine Piccart, ESMO President
Cora Sternberg, Co-scientific Chair
John Yarnold, Co-scientific Chair
Marcel Verheij, National Organising Committee Chair